
Loading, please wait...

Loading, please wait...

Hydrocephalus significantly impacts infant health in many developing nations. While many centers traditionally use shunts, ETV in infants is gaining popularity due to fewer hardware-related complications. A landmark study from Tanzania recently evaluated the clinical success and patterns of presentation for neonates undergoing this procedure. Surgeons often combine endoscopic third ventriculostomy (ETV) with choroid plexus cauterization (CPC) to improve long-term outcomes.
The researchers analyzed a cohort of 325 infants with a median age of 86 days. They found that neonates younger than two months achieved a 95% success rate at four weeks postoperatively. In contrast, infants older than two months had a slightly lower success rate of 88%. This initial difference was statistically significant. However, by the 52nd week, the failure rates leveled out at approximately 60% for both groups. Consequently, clinicians should consider ETV even in the youngest patients, as age does not necessarily dictate long-term failure.
Congenital hydrocephalus was the most common etiology in this cohort, affecting 69% of the infants. Furthermore, the use of ETV and combined ETV/CPC showed better clinical outcomes than ventriculoperitoneal (VP) shunting in this specific population. This is particularly important because shunts often carry a high risk of infection and blockage. Moreover, endoscopic procedures avoid the need for permanent internal hardware, which simplifies long-term management in regions with limited follow-up care.
Several supporting studies also highlight the benefits of endoscopic techniques. Specifically, research indicates that ETV is associated with shorter operative times and significantly lower postoperative infection rates. While shunting remains a valid option, the high rate of hardware malfunction often leads to frequent revision surgeries. Therefore, ETV/CPC stands out as a reliable first-line treatment for obstructive hydrocephalus in African neonates. Additionally, careful patient selection remains vital for optimizing surgical results.
Research indicates an immediate success rate as high as 95% in neonates younger than two months, though long-term success at one year stabilizes around 60%.
Yes, combined ETV and CPC often show better clinical outcomes and lower infection rates compared to traditional ventriculoperitoneal shunting in this demographic.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Shayo CS et al. The pattern and outcome of infants and neonates undergoing endoscopic third ventriculostomy in Tanzania: an observational cohort study. J Neurosurg Pediatr. 2026 Feb 27. doi: 10.3171/2025.10.PEDS24668. PMID: 41759095.
Abdel-Aziz K, Nouby R, Thabet M, Elshirbiny M. Endoscopic Third Ventriculostomy versus Ventriculo-Peritoneal Shunt for Infant Hydrocephalus. Open Journal of Modern Neurosurgery. 2020;10:193-202. doi: 10.4236/ojmn.2020.102020.
Patel PB, Lodha KG, Jaiswal G, et al. Endoscopic third ventriculostomy versus ventriculoperitoneal shunt for treatment of hydrocephalus in infants in a tribal population. London Academic Publishing. 2021.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study on infants in Tanzania shows that ETV/CPC offers high success rates for hydrocephalus, often outperforming traditional shunts in neonates....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today